Global Biomedical Textiles Market

Report ID : 1480 | Published : 2022-12-01 | Pages: | Format: PDF/EXCEL

The market size of the Global Biomedical Textiles Market in the year 2021 is valued at 13.51 billion and is predicted to reach 24.67 billion by the year 2030 at an 7.10% CAGR during the forecast period.

Fibrous textiles, called biomedical textiles, are used for biological and medical purposes. The biocompatibility textiles are used in surgeries, first aid, and to keep a space sterile. To function properly, such fabrics must be biocompatible with biological tissues and fluids. The rise in the older population, increased healthcare spending, and high demand for biomedical textiles and sophisticated wound dressings are the main factors propelling market revenue development. In addition, biomedical textiles are frequently used to produce first-aid items like bandages and wound dressings because of their remarkable characteristics like filtration, lightness, and absorption.

Additionally, a significant element propelling the market's revenue growth over the anticipated period is the ongoing development of smart biomedical textiles and medical technology improvements. A growing number of techniques, particularly for less invasive surgical operations, are being developed due to the quick advancement of medical knowledge. Modern medical advances have used biomedical textiles to replace damaged tissues or organs. Orthopedic surgeons more frequently utilize non-woven non-woven fiber mats with Teflon and graphite to promote tissue formation around orthopedic implants. While these implants replace bones and joints, fixation plates stabilize fractured bones. It is anticipated that these elements will increase demand for biomedical textiles.

Market Segmentation:

The biomedical textiles market is segmented on fiber, fabric, and application. Based on fiber type, the market is segmented into non-biodegradable and biodegradable. Based on application, the biomedical textiles market is segmented into surgical sutures and non-implantable. Based on the fabric type, the biomedical textiles market is segmented into non-woven, non-woven and woven.

Based on fiber type, the non-woven segment is a major contributor to the biomedical textiles market.

The non-woven non-woven market is anticipated to increase steadily throughout the projected period. As they work to avoid cross-contamination and the spread of infection in a medical or surgical environment, the non-woven non-woven fabric offers essential safety qualities, including prevention against infections and diseases. Non-wovens-wovens are also increasingly employed in creating intelligent wound care solutions, including encouraging moist wound healing conditions, lowering skin adhesion, and regulating vapor transfer. Several biomedical textiles use non-woven non-woven fabrics, including sheets, tubes, gowns, face masks, scrub suits, shoe covers, head covers, sponges, wipes, and plugs. Non-woven-woven fabrics are frequently used in surgical dressings, bandages, and implant applications.

The non-biodegradable segment witnessed growth at a rapid rate.

The non-biodegradable market is anticipated to expand quickly throughout the forecast period. The production of biomedical textiles, intended to close open wounds and remove them once the wound has fully healed, is increasingly using non-biodegradable fibers, causing this segment's income to expand. Surgical sutures, bandages, extracorporeal devices, and soft and hard tissue implants treat wounds. Polypropylene, viscose, polyester, polyethylene, and polyamide are non-biodegradable fibers that prevent bacteria from colonizing sutures.

The North American biomedical textiles market holds a significant regional revenue share.

The North American market is anticipated to have the greatest revenue share in the global market due to an increase in home healthcare services. The rapid increase in elderly people and the demand for services to diagnose diabetes are anticipated to propel market revenue growth in this area over the forecast year. Besides, the Asia Pacific market to experience a very high rate of revenue growth over the upcoming years due to the rise in chronic wounds and surgical treatments is likely to cause. Additionally, rising healthcare spending and the swift expansion of the healthcare sector in developing nations like China and India fuel the market's revenue growth.

Competitive Landscape

Some major key players in the Biomedical Textiles market are Paul Hartmann (Germany), BSN Medical (Sweden), Royal DSM (Netherlands), Covidien (Ireland), Integra Life Sciences (US), Johnson & Johnson (US), Smith & Nephew (UK), Medline Industries (US), B.Braun Melsungen (Germany), and Cardinal Health (US).

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Biomedical Textiles Market Snapshot

Chapter 4. Global Biomedical Textiles Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Fiber Type Estimates & Trend Analysis

5.1. by Fiber Type & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Fiber Type:

5.2.1. Biodegradable

5.2.2. Non-biodegradable

Chapter 6. Market Segmentation 2: by Fabric Type Estimates & Trend Analysis

6.1. by Fabric Type & Market Share, 2019 & 2030

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Fabric Type:

6.2.1. Non-Woven

6.2.2. Woven

6.2.3. Others

Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis

7.1. by Application & Market Share, 2019 & 2030

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Application:

7.2.1. Non-Implantable

7.2.2. Surgical Sutures

7.2.3. Others

Chapter 8. Biomedical Textiles Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Fiber Type, 2022-2030

8.1.2. North America Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Fabric Type, 2022-2030

8.1.3. North America Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.1.4. North America Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.2. Europe

8.2.1. Europe Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Fiber Type, 2022-2030

8.2.2. Europe Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Fabric Type, 2022-2030

8.2.3. Europe Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.2.4. Europe Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Fiber Type, 2022-2030

8.3.2. Asia Pacific Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Fabric Type, 2022-2030

8.3.3. Asia-Pacific Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.3.4. Asia Pacific Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.4. Latin America

8.4.1. Latin America Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Fiber Type, 2022-2030

8.4.2. Latin America Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Fabric Type, 2022-2030

8.4.3. Latin America Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.4.4. Latin America Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Fiber Type, 2022-2030

8.5.2. Middle East & Africa Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Fabric Type, 2022-2030

8.5.3. Middle East & Africa Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by Application, 2022-2030

8.5.4. Middle East & Africa Biomedical Textiles Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Paul Hartmann (Germany)

9.2.2. BSN Medical (Sweden)

9.2.3. Royal DSM (Netherlands)

9.2.4. Covidien (Ireland)

9.2.5. Integra Life Sciences (US)

9.2.6. Johnson & Johnson (US)

9.2.7. Smith & Nephew (UK)

9.2.8. Medline Industries (US)

9.2.9. B.Braun Melsungen (Germany)

9.2.10. Cardinal Health (US)

9.2.11. Other Prominent Players

By Fiber Type

  • Biodegrable
  • Non-Biodegrable

By Fabric Type

  • Non-Woven
  • Woven
  • Others

By Application:

  • Npn-Implantable
  • Surgical Sutures
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients